Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Mar 1997, 570-577, Vol 35, No. 3
T Ando, SS Monroe, JS Noel and RI Glass
Amplification of a 3-kb genome region from the RNA polymerase gene to the
3' poly(A) tail of small round-structured virus (SRSV) by reverse
transcription-PCR (RT-PCR) has been difficult to achieve because of a
stable secondary structure in a region between the RNA polymerase gene and
the 5' end of the second open reading frame. We have developed a one-tube
RT-PCR method to efficiently amplify this region. The method comprises
three procedures: purification of poly(A)+ RNA from a starting RNA solution
by oligo(dT)30 covalently linked to latex particles, buffer exchange, and
continuous RT and PCR in a single tube containing all reaction components.
The key elements of this method are (i) first-strand cDNA synthesis with
the Superscript II version of RNase H- Moloney murine leukemia virus
reverse transcriptase at 50 degrees C for 10 min by using the
RNA-oligo(dT)30 hybrid on the latex particles as the template and primer,
and (ii) PCR by Taq and Pwo DNA polymerases mixed together with a mixture
of 12 phased oligo(dT)25 antisense primers. The detection threshold of the
one-tube RT-PCR method was as little as 0.2 ng of the crude RNA used as the
source of the template. Using this method, we obtained 3-kb products from
24 SRSV strains previously characterized into four genetic groups. These
included 5 P1-A, 4 P1-B, 5 P2-A, and 10 P2-B strains. Because SRSVs have
not yet been cultivated in vitro, this novel method should facilitate
molecular characterization of SRSVs to provide a firm scientific foundation
for improvements and refinements of SRSV diagnostics.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
A one-tube method of reverse transcription-PCR to efficiently amplify a 3-kilobase region from the RNA polymerase gene to the poly(A) tail of small round-structured viruses (Norwalk-like viruses)
Viral Gastroenteritis Section, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. txa5@CIDDVD1.em.cdc.gov
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|